PharmaCyte Biotech Inc. (PMCB): Price and Financial Metrics
PMCB Price/Volume Stats
| Current price | $1.72 | 52-week high | $2.58 |
| Prev. close | $1.85 | 52-week low | $1.39 |
| Day low | $1.70 | Volume | 6,700 |
| Day high | $1.87 | Avg. volume | 24,560 |
| 50-day MA | $1.79 | Dividend yield | N/A |
| 200-day MA | $1.99 | Market Cap | 13.21M |
PMCB Stock Price Chart Interactive Chart >
PharmaCyte Biotech Inc. (PMCB) Company Bio
PharmaCyte Biotech, Inc. (PharmaCyte) is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.
PMCB Price Returns
| 1-mo | -6.01% |
| 3-mo | 3.61% |
| 6-mo | -19.63% |
| 1-year | -22.17% |
| 3-year | -31.47% |
| 5-year | -96.65% |
| YTD | -20.37% |
| 2023 | -26.28% |
| 2022 | 17.20% |
| 2021 | -75.12% |
| 2020 | -83.46% |
| 2019 | 9.46% |
Loading social stream, please wait...